Search Results - "Malkin, Samuel Joseph Paul"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy by Ren, Hongye, Berry, Sasha, Malkin, Samuel Joseph Paul, Hunt, Barnaby, Bain, Stephen

    Published in BMJ open (29-09-2023)
    “…ObjectivesMany people with type 2 diabetes experience clinical inertia, remaining in poor glycaemic control on oral glucose-lowering medications rather than…”
    Get full text
    Journal Article
  2. 2

    The Short-Term Cost-Effectiveness of a Fixed-Ratio Combination of Insulin Degludec and Aspart: A Cost of Control Analysis in Australia and India by Romano, Jack Garcia Uranga, Malkin, Samuel Joseph Paul, Hunt, Barnaby

    Published in Value in health regional issues (01-05-2024)
    “…The real-world ARISE study demonstrated initiation of fixed-ratio combination insulin degludec and aspart (IDegAsp) led to improvements in people achieving key…”
    Get full text
    Journal Article
  3. 3

    Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting by Gæde, Peter, Johansen, Pierre, Tikkanen, Christian Klyver, Pollock, Richard Fulton, Hunt, Barnaby, Malkin, Samuel Joseph Paul

    Published in Diabetes therapy (01-08-2019)
    “…Introduction Once-weekly semaglutide is a novel glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes (T2D) that has been associated with…”
    Get full text
    Journal Article
  4. 4